Is Jazz Pharmaceuticals plc (JAZZ) a Buy, Sell, or Hold?
NASDAQ : JAZZ
Jazz Pharmaceuticals plc — Analyst Ratings
$252.86 USD
-$5.52 (-2.14%)
- Volume
- 561.21K
- Average Volume
- 870.77K
- Market Capitalization
- $15.88B
- P/E Ratio
- 616.73
- Dividend Yield
- 0.00%
- Price Target
- $260.00
- Year High
- $261.30
- Year Low
- $105.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.04
Analyst Consensus Summary
Consensus Rating
Neutral
48 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-2.7%
vs Current Price
Price Target
$260.00
Average TargetPrice Target Range
Lowest Target
$229.00
10.4% UPSIDE
Average Target
$260.00
Median Estimate
Highest Target
$307.00
-17.6% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 48
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 43 | 5 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Canaccord Genuity | Gary Nachman | $290 | $242.18 | 2026-07-16 04:13 PM | 19.7% |
| Truist Financial | Gregory Renza | $254 | $245.5354 | 2026-07-07 09:14 AM | 3.4% |
| Truist Financial | Gregory Renza | $256 | $232.04 | 2026-06-09 06:06 AM | 10.3% |
| UBS | Ashwani Verma | $307 | $229.55 | 2026-05-19 04:41 AM | 33.7% |